US opioid activists argue against Sackler family immunity in Purdue Pharma deal
Supreme court to review immunity of Sacklers from prosecution under a 2019 bankruptcy settlement with the OxyContin maker
Stay updated with breaking news from Ryan Wroblewski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Supreme court to review immunity of Sacklers from prosecution under a 2019 bankruptcy settlement with the OxyContin maker
Purdue Pharma, the maker of OxyContin, filed for Chapter 11 bankruptcy protection in September 2019 after they faced scores of lawsuits related to the opioid crisis.
Purdue Pharma, the maker of OxyContin, filed for Chapter 11 bankruptcy protection in September 2019 after they faced scores of lawsuits related to the opioid crisis.
The agreement by the maker of OxyContin to settle thousands of lawsuits over the harm done by opioids could help combat the overdose epidemic that the painkiller helped spark. But that does not mean all the victims are satisfied.
The legality of an agreement by the maker of OxyContin to settle thousands of lawsuits over the harm done by opioids is going before the Supreme Court. Families that lost